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Cell death inside articular cartilage was examined by TUNEL assay.
Expression of catabolic, inﬂammatory, and anabolic factors such as
MMP3, MMP13, cathepsin F, IL1b, IL6, type II collagen and type X col-
lagen mRNA in cartilagious tissues of :7CKO and Cont mice was quan-
titated by Q-PCR.
Results: In this study, we found that the absence of locally produced
Bmp7 reduced proteoglycan contents in articular cartilage matrix in the
adult mice (at 8 and 24 weeks of age). This may not be due to the defect
in cartilage formation since there was no signiﬁcant alteration in both
articular structure and proteoglycan contents in the juvenile :7CKO
mice (at 4 weeks of age). Structural analyses of articular cartilage
indicated that cartilage thickness and chondrocyte density were not
signiﬁcantly altered between the genotypes at 8 and 24 weeks of age.
TUNEL assay revealed that elimination of Bmp7 expression did not
affect chondrocyte survival at 8 weeks of age. Histological evaluation
revealed that extensive synovial hyperplasia was observed at 8 and 24
weeks of age in the absence of Bmp7. F4/80 staining revealed that
extensive numbers of macrophages were inﬁltrated in the synovial
tissues of :7CKO mice at these stages suggesting that severe synovitis
occurred in the absence of Bmp7. In contrast, appearance of synovial
membrane was quite similar between the genotypes at 4 weeks of age.
Q-PCR analyses revealed that mRNA expression levels of all the genes
examined (see above) in articular cartilage were not signiﬁcantly
altered between the genotypes at 24 weeks of age.
Conclusions: Our data showed that the absence of endogenous Bmp7,
although does not affect articular cartilage formation and survival of
articular chondrocyte, but enhance articular cartilage degeneration and
synovial inﬂammation in adult mice.
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EPIGENETIC MODIFYING COMPOUNDS ALTER ACTIVITY OF PRIMARY
HUMAN ARTICULAR CHONDROCYTES AND MESENCHYMAL STEM
CELLS UNDERGOING CHONDROGENESIS
S. Snelling, A. Kramm, C. Yapp, A. Carr, U. Oppermann. Univ. of Oxford,
Oxford, United Kingdom
Purpose: A major therapeutic challenge in osteoarthritis is to identify
disease modifying therapeutics. No current therapies cause cessation or
reversal of cartilage loss. Suitable therapeutics may target the chon-
drocytes or stem cells resident within the diseased cartilage or expan-
ded in vitro prior to implantation. Epigenetic regulation of cell behavior
is essential for both correct development and homeostasis of cartilage
(1). This epigenetic control does not alter the DNA sequence and allows
modiﬁable changes to gene expression that are heritable. Thus allowing
a cell to respond to environmental and biological cues. Targeting the
epigenetic modifying machinery can therefore provide important clues
to the biology of chondrocyte differentiation and homeostasis and to
potential targets for therapeutic intervention.
Our library of epigenetic modifying compounds includes those target-
ing methyltrasnferases, histone deacetylases, histone protein kinases
and bromodomains. In this preliminary work we have screened this
library for impact on cell phenotype in chondrogenesis and in primary
human articular chondrocytes (HAC)
Methods: Primary human articular chondrocytes (HAC) and human
mesencymal stem cells (MSCs) undergoing chondrogenesis were trea-
ted with epigenetic modifying compounds for 72 hours. Metabolic
activity was assessed after 72h using Prestoblue before cells were ﬁxed
and assessed for cell number (DAPI count), ECM production (Alcian
blue) and nodule formation (Nile Red). HAC were treated with GSK-J4
and GSK-J5 for 6h and TIMP3 and COL2A1 expression assessed by qPCR.
HAC were treated with GSK-J4 and GSK-J5 for 3h in the presence and
absence of 2ng/ml TGFb and expression JMJD3 and the TGFb target gene
TIMP3 was assssed by qPCR.
Results: Compounds including Methylstat, an inhibitor of the Jumonji C
domain-containing histone trimethyl demethylases caused an increase
in the metabolic activity and cell number of MSCs and HAC, whilst 5-
iodotubercidin increasedmetabolic activity inMSCs only. GSK-J4, which
blocks H3K27 demethylation decreased metabolic activity and cell
number in MSCs and HAC. ECM accumulation in chondrogenesis were
reduced by compounds including GSK-J4 whilst ECM accumulation was
increased by the PARP inhibitor Rucaparib.
COL2A1 and TIMP3 expressionwas reduced in HAC treated with GSK-J4,
but not HAC treated with the inactive isomer GSK-J5. Treatment of HAC
with TGFb increased the expression of the H3K27 demethylase JMJD3and the TGF-responsive gene TIMP3. In the presence of GSK-J4 the TGF-
induced JMJD3 and TIMP3 expression was inhibited.
Conclusions: This preliminary screen demonstrates the utility of epi-
genetic modifying compounds in the regulation of chondrogenesis and
HAC behavior. We have shown that epigenetic regulation can both
enhance and inhibit chondrogenesis and can also alter the phenotype of
HAC. The differential effects of compounds in HAC and MSC indicates
the importance of ﬁne and temporally correct regulation of epigenetic
activities during chondrocyte differentiation and homeostasis. Early
investigations on the role of GSK-J4, which inhibits the histone deme-
thylase JMJD3, in HAC suggest JMJD3 as an important epigenetic target
through its ability to regulate TGFb signaling.
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FIBRILLIN-1 EXPRESSION, WHICH REGULATES OF TGF-B
BIOAVAILABILITY, IS MODIFIED DURING OSTEOARTHRITIS AND
MUTATIONS LEAD TO OSTEOARTHRITIS
W. Ramanayake y, H. Jones z, I. Orriss x, T. Arnett y, A. Pitsillides x,
C. Denton y, D. Abraham y, B. Poulet y. yUniv. Coll. London, London, United
Kingdom; zUCL, London, United Kingdom; xRoyal Vet. Coll., London,
United Kingdom
Purpose: The TGFb signalling pathway has been shown to play a major
role in joint homeostasis and in osteoarthritis development. Fibrillin-1
is an extracellular matrix protein that may play a structural role in the
matrix of articular cartilage. Fibrillin rich microﬁbrils (especially
ﬁbrillin-1) help in the regulation of TGFb activity by controlling its
bioavailability to the cell. Thus Fibrillin-1 mutations, such as those
seen in the Tight Skin mouse (or TSK), have been shown to increase
TGFb signalling. The TSK mouse displays tight skin, myocardial
hypertrophy, marfan-like skeletal phenotype and lung emphysema,
but no studies have yet investigated the effect of Fibrillin-1 mutation
on joint health. The aim of this study is therefore to determine
changes in ﬁbrillin-1 expression during osteoarthritis in mice and to
characterise the effect of Fibrillin-1 mutations in ageing-induced OA
development in TSK mice.
Methods: Immunohistochemistry for Fibrillin-1 expression was per-
formed in Str/ort mice, a known model of spontaneous OA, and in
control aged-matched non-OA CBA mice, in knee joints with different
degrees of OA severity. The knees of TSK and littermate control male
mice of 60-80wks of age were ﬁxed and microCT scanned. Abnormal
ectopic calciﬁed regions were analysed. After scanning, joints were
decalciﬁed and processed for parafﬁn embedding; serial coronal sec-
tions were cut at 6um and sections at regular intervals stained with
Toluidine Blue.
Results: Fibrillin-1 was localised in the pericellular matrix of articular
chondrocytes in normal joints. During the development of OA in Str/ort
mice, however, Fibrillin-1 immunolabelling was decreased, in particular
around articular cartilage lesions. TSK mice microCT images showed
important ectopic calciﬁcation and ossiﬁcation in various ligaments,
including patella and collateral ligaments, as well as osteophyte for-
mation on the margins of the joints. Preliminary data suggest that
articulate cartilage degradation was increased in TSK mice compared to
aged-matched control mice suggesting a role of Fibrillin-1 in joint
health and osteoarthritis development.
Conclusion: Our preliminary study shows that Fibrillin-1 protein
expression is decreased during OA development in a well knownmodel
of spontaneous OA, suggesting TGFb bioavailability may be modiﬁed
during this period. In addition, mutations in Fibrillin-1 in the TSK
mouse lead to abnormal ossiﬁcation in the knee joint as well as severe
OA development. These data suggest that Fibrillin-1 plays an important
role in joint homeostasis and that abnormal expression or mutations in
its gene can lead to OA development.
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DYNAMIC CHANGES OF EXTRA CELLULAR MATRIX PROTEINS IN
EQUINE ARTICULAR CARTILAGE TREATED WITH INTERLEUKIN-1B
IN VITRO
E. Svala y,z, M. L€ofgren y, C. Sihlbom x, U. R€uetschi y, A. Lindahl y,
S. Ekman y, E. Ski€oldebrand y,z. , Major contributor: late Professor Dick
HeinegardyBioMed. Sci. and Vet. Publ. Hlth., Swedish Univ. of Agricultural
Sci., Uppsala, Sweden; z Inst. of Biomedicine, Sahlgrenska Univ. Hosp.,
Gothenburg Univ., Gothenburg, Sweden; x Proteomics Core Facility,
Sahlgrenska Academy,Univ. of Gothenburg, Gothenburg, Sweden
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S142Purpose: Osteoarthrtitis (OA) is a chronic low-grade inﬂammatory
disease for which the diagnosis currently relies on clinical and radio-
logical means whereas sensitive serum biomarkers speciﬁc for an early
stage of the disease are lacking. The aim of the study was to identify
speciﬁc molecular alterations of articular cartilage in an in vitro
inﬂammation model. The pro-inﬂammatory cytokine interleukin (IL)-
1b was used to induce degradation of articular cartilage explants cul-
tured in vitro with the purpose of mimicking OA cartilage in early and
later developmental stages. The speciﬁc objective was to longitudinally
characterize and quantify the release of cartilage matrix components to
the media by using a quantitative proteomic approach.
Methods: Full thickness equine articular cartilage explants were har-
vested from the weight bearing part of the distal metacarpal bone III in
the metacarpal-phalangeal joint of three horses. The explants were
cultured in the presence or absence of interleukin IL-1b in-vitro and cell
mediawas changed and sampled at day 3, 6, 9,12,15,18 and 22. Proteins
were isolated from the harvested media and following tryptic digestion
the peptides were labeled with isobaric tandem mass tags (TMT) and
analyzed by liquid chromatography-mass spectrometry (LC-MS/MS).
The TMT reporter ion intensities in MS/MS spectra were divided by
reference reporter ion intensities, giving a relative amount for each
quantiﬁed peptide. The relative amount of released components in
media from IL-1b stimulated and unstimulated explants were com-
pared over time.
Results: IL-1b stimulation resulted in an abundance of proteins related
to the extra cellular matrix and the proteins were released at different
time points during culturing time. Release of several cartilage matrix
components e.g. aggrecan, cartilage oligomeric matrix protein (COMP),
chondroadherin, thrombospondin-1 and proteoglycan 4 displayed high
amounts at days 3 and 6, similar to the early stage of the disease process
of OA in vivo. Collagen type XII release was identiﬁed at day 9 and 12
and the release of collagen type VI increased continually from day 18-
22. Several small leucine-rich proteoglycans (SLRP) such as biglycan and
lumican had the highest release at day 22, together with a high amount
of collagen type II in IL-1b stimulated media. The unstimulated media
showed signs of new synthesis of collagen type II, by the presence of
high amount of procollagen type II C-propeptide and C endopeptidase
enhancers, and this collagen synthesis was not at all prominent in the
IL-1b stimulated media.
Conclusions: This inﬂammatory in vitro model display structural
changes seen at distinct developmental stages of OA in vivo. Novel
ﬁndings presented are the release, at different time points after IL-1b
stimulation, of cartilage components in a speciﬁc time pattern in the
order as follows; COMP, collagen type XII, collagen type VI, SLRPs and
ﬁnally collagen type II, indicating a degradation of the collagen network
in a distinct pattern, without evidence for new synthesis of collagen
type II. The results from the unstimulated explants indicate repair
capacity with an increase of collagen synthesis. The identiﬁcation of
early biochemical changes in cartilage would be of great importance in
both ﬁnding diseasemodifying pharmaceutical compounds aswell as in
the development of biomarkers for early OA.
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IMMUNOHISTOCHEMICAL LOCALIZATION OF NOTCH SIGNALING
COMPONENTS, MATRIX COMPONENTS AND STRO-1 IN PRENATAL,
POSTNATAL AND OSTEOARTHRITIC EQUINE CARTILAGE
M. L€ofgren y, S. Ekman y, C. Ley y, A. Lindahl z, E. Svala y,z,
E. Ski€oldebrand y,z. , Major contributor: late Professor Dick
HeinegardyDept. of BioMed. Sci. and Vet. Publ. Hlth., Swedish Univ. of
Agricultural Sci., Uppsala, Sweden; zDept. of Clinical Chemistry and
Transfusion Med., Inst. of Biomedicine, Sahlgrenska Univ. Hosp.,
Gothenburg Univ., Gothenburg, Sweden
Purpose: The growth plate and articular cartilage of developing syno-
vial joints include speciﬁc zones of chondrocytes with different phe-
notypes. The chondrocytes in the growth plate change from resting to
proliferative and hypertrophic phenotypes. Phenotypical changes also
occur in the chondrocytes of the articular cartilage during the pro-
gression of osteoarthritis (OA). The expression of proteins on the
chondrocytes as well as in the surrounding matrix affects the pheno-
type and can be used to characterize cells of speciﬁc phenotypes.
The aim of the study was to localize components with potential effects
on the phenotype such as the Notch signaling components including
the receptor Notch1, the ligand Delta4 and the target gene Hes1.
Additionally the stem cell indicating marker Stro-1 and matrixmolecules were localized to further characterize cells and matrix in
developing prenatal and postnatal equine cartilage as well as in OA
cartilage.
Methods: Immature equine osteochondral tissues, representing dif-
ferent developmental stages of the articular and growth cartilage of the
distal radius were collected post mortem from two fetuses (6.5 and 10
months gestational age) and from two young horses (2-day-old and 1-
year-old). Articular cartilage from fetlock joints of adult horses was
collected and articular cartilage with superﬁcial chondronecrosis,
ﬁbrillation and adjacent cluster formations, compatible with OA carti-
lage was identiﬁed by histology and included in the study. The local-
ization of Notch signaling components, Stro-1 and the matrix molecules
cartilage oligomeric matrix protein (COMP), ﬁbromodulin, chon-
droadherin and matrilin-1 was examined by immunohistochemistry.
Results: Notch1, Delta4 and Hes1 indicating active Notch signaling was
localized in hypertrophic cells in growth plates of the distal radius in all
horses, as well as in resting cells of prenatal horses and in proliferative
cells of the youngest fetus. The same proteins were present in all zones
of the radial articular cartilage of the postnatal horses, whereas only a
few cells were stained in the youngest fetus.
Stro-1 was present in the resting zone of the youngest fetus, with weak
immunolabeling in the resting zone of the 10-month-old fetus and only
detected as weak immunolabeling in the proliferative zone of the 2-
day-old horse and not detected in the growth plate of the 1-year-old
horse. In articular cartilage the chondrocytes stained positive for Stro-1
in all zones of the youngest fetus, whereas the staining became
restricted to the superﬁcial and middle zones in the postnatal horses.
Most matrix molecules gradually changed in location with increasing
age from interterritorial to pericellular location in the growth plates. The
most prominent changes were observed in the hypertrophic zone where
COMP, ﬁbromodulin and chondroadherin were localized interterrito-
rially in the prenatal horses but shifted to a pericellular location in the
postnatal horses. Matrilin-1 was present in the hypertrophic zone of the
prenatal horses but absent in the postnatal horses. In the articular car-
tilage thematrix molecules were present in all zones with an age related
shift from interterritorial to pericellular location in all zones but the
superﬁcial zone, which displayed interterritorial staining in all horses.
The Notch1 receptor and the Delta4 ligand were detected in all zones of
OA cartilage with the strongest staining in the superﬁcial zone and in
cell clusters. Intense Stro-1 and weak Hes1 immunolabeling was
detected in the superﬁcial zone and in cell clusters. All matrix compo-
nents were present in OA cartilage.
Conclusions: This study demonstrates presence of Notch signaling
components in equine cartilage of different developmental stages
which support previous ﬁndings of a role for Notch signaling in endo-
chondral ossiﬁcation and differentiation of chondrocytes. The studied
matrix molecules known to be involved in the formation and organ-
ization of the collagen network showed age related differences in
localization of the molecules, which may indicate increased mechanical
load or altered expression related to different developmental stages.
The weak staining of Hes1 in OA cartilage suggests low activity of the
Notch1 signaling, and the strong staining of Stro-1 in the superﬁcial
zone and OA cell clusters indicates stem cell like characteristics of the
chondrocytes. This is the ﬁrst study demonstrating the localization of
Notch signaling components, Stro-1 and matrix components in equine
growth cartilage of different developmental stages and OA cartilage.
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OSTEOCLASTS REDUCE THE ACTIVATION OF WNT CANONICAL
PATHWAY IN CHONDROCYTES
C. Cheriﬁ, W. Bouaziz, M. Cohen-Solal, E. Hay. Inserm U1132, Paris,
France
Purpose: Osteoclastogenesis is enhanced in early osteoarthritis (OA).
We have previously demonstrated that cartilage degradation is reduced
in vivo when osteoclastogenesis is inhibited in murine models with
high bone resorption. Wnt activity, known to regulate the bone and
chondrocyte cell function, might contribute to the mechanisms that
promote cartilage breakdown. Our purpose was to evaluate whether
osteoclast-secreting molecules affect directly the metabolism of chon-
drocyte and the contribution of Wnt pathway.
Methods: Osteoclasts were obtained after differentiation of RAW cells
cultured with RANKL. Primary murine chondrocyte (Ch) were then
cultured in the presence of osteoclast conditioned medium (Oc-CM) for
48h. The gene and protein expressions of catabolism and anabolism
